PEAR-GLIO Patient & Public Involvement & Engagement Sessions – Pear Bio
Our drug discovery pipeline is focused on a range of indications from breast to lung cancer. Explore more about our pipeline.
Related Articles
Huntsman Cancer Institute Leader Appointed Editor-in-Chief of Journal of the American College of Surgeons
Varghese Jr. becomes just the eighth Editor-in-Chief during the 119-year history of the JACS, where he will be tasked with driving innovation and inspiring the…
NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs
The NMPA has approved belzutifan for von Hippel-Lindau disease in RCC, CNS hemangioblastomas, or pNETs not requiring immediate surgery.
HRD Testing in Advanced Ovarian Cancer
In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we’ re speaking with…
Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma
Inhibition of catechol-O-methyltransferase, a well-established drug target in Parkinson’s disease, interferes with mitochondrial electron transport and induces mitochondrial double-stranded RNA leakage, activating type I interferon…
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Abstract. Precision oncology tailors treatment strategies to a patient’s molecular and health data. Despite the essential clinical value of current diagnostic methods, hematoxylin and eosin…
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases
This randomized clinical trial examines different treatments for patients with unresectable colorectal cancer with liver-only metastases.
Exploring pancreatic cancer vaccines: What’s next?
Discover the latest advancements in pancreatic cancer vaccines and how they aim to prevent recurrent cancer by targeting specific mutations. Stay informed with current trials…
Fine‐needle aspiration and effusion cytology of thoracic SMARCA4–deficient undifferentiated tumor and SMARCA4‐deficient non–small cell lung carcinoma: A multi‐institutional experience with 27 patients
The cytomorphologic features of thoracic SMARCA4–deficient malignancies are not entirely specific but are distinctive enough to suspect the diagnosis in the appropriate clinical setting. The…
ASH in a Flash – Race and Ancestry in Precision Medicine – Dr. Sant-Rayn Pasricha
Introducing #ASHinaFlash, your fast track to essential #ASH24 content! Get expert highlights of must-see sessions and quick takes on the latest #hematology b…
